Results 171 to 180 of about 9,858 (221)
Assessment of Conventional Oxygen Therapy, High-Flow Nasal Cannula, and Non-Invasive Ventilation to Secure Bronchofiberoscopy in Patients with Respiratory Acidosis: A Narrative Review and a Proposal for a Protocol in View of a Randomized Multicenter Study. [PDF]
Rycerski M +10 more
europepmc +1 more source
Application of the TIDieR checklist to improve the HFNC use in bronchiolitis management
The use of High-Flow Nasal Cannula (HFNC) in children with bronchiolitis is globally increased in the last decade, despite the lack of evidence-based and universal guidelines to standardize their application in the clinical practice. In this systematic review, we aimed to analyse the completeness of previous studies on HFNC interventions in children ...
Sara, Manti +3 more
exaly +5 more sources
This is a single-center, randomized, physiological cross-over study designed to evaluate the impact of three non-invasive respiratory support strategies (Helmet CPAP, High-Flow Nasal Cannula [HFNC], and their combination) on inspiratory effort in critically ill patients with acute hypoxemic respiratory failure.
Lassola, Sergio +2 more
openaire +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
CPAP versus HFNC use in carbon monoxide poisoning
American Journal of Emergency Medicine, 2021Kasım, Turgut, Erdal, Yavuz
exaly +3 more sources
1216: IMPLEMENTATION OF AN HFNC WEANING PROTOCOL IN SHORTENING THE DURATION OF HFNC USE IN THE PICU
Critical Care Medicine, 2019Katherine Slain +2 more
exaly +2 more sources
2020
Acute respiratory infection due to 2019 novel coronavirus (2019-nCoV) is now known as novel coronavirus-infected pneumonia (NCIP). In the hospitalized NCIP patients, the time from disease onset to shortness of breath was median 8 days and to development of ARDS was median 10.5 days. Most of the patients received oxygen therapy.
Giuseppe Fiorentino +3 more
openaire +1 more source
Acute respiratory infection due to 2019 novel coronavirus (2019-nCoV) is now known as novel coronavirus-infected pneumonia (NCIP). In the hospitalized NCIP patients, the time from disease onset to shortness of breath was median 8 days and to development of ARDS was median 10.5 days. Most of the patients received oxygen therapy.
Giuseppe Fiorentino +3 more
openaire +1 more source
What HFNC indication are we doing in RICU?
Acute critical care, 2020Introduction: High-flow therapy (HFT) has changed the activity in RICU. The purpose of this analysis is to find out the indications of HFT in our unit compared to non-invasive mechanical ventilation. Methods: Patients admitted in 2019 were prospectively registered.
Muniz, AM +6 more
openaire +3 more sources
2020
A 42 years old female, non smoker presented with fever, nasal discharge, cough and shortness of breath for the last five days. On examination, patient was conscious, RR 38/min, SPO2 80% on nasal prongs with 5 L/min, BP 130/70. His TLC was 5.2. Chest X-ray revealed bilateral infiltrates. Her throat swab came out as + H1N1.
Rajesh Chawla, Subhash Todi
openaire +1 more source
A 42 years old female, non smoker presented with fever, nasal discharge, cough and shortness of breath for the last five days. On examination, patient was conscious, RR 38/min, SPO2 80% on nasal prongs with 5 L/min, BP 130/70. His TLC was 5.2. Chest X-ray revealed bilateral infiltrates. Her throat swab came out as + H1N1.
Rajesh Chawla, Subhash Todi
openaire +1 more source
NPPV vs. HFNC for Acute Respiratory Failure
2020The most recent clinical practice guidelines by ERS/ATS for the use of NIV for ARF were published in 2017. These guidelines focused mainly on NIPPV. We will review these guidelines and analyze studies that followed temporally, focusing on new applications of NIPPV, data for the use of HFNC, as well as any comparisons between the two strategies.
Daniel Zapata +3 more
openaire +1 more source

